Who
Third Rock Ventures V, L.P.
10% owner
Company insider
Files Form 4 as: 10% owner, Septerna; 10% owner, Rapport Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $47.9M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Jun 2024
- Last trade
- 12 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 14 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $7.4M147,059 at $50.27 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $7,202141 at $51.08 | filing |
| 26 May 2026filed 28 May 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $744K18,572 at $40.05 | filing |
| 26 May 2026filed 28 May 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $744K18,572 at $40.05 | filing |
| 11 May 2026filed 13 May 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $5.4M133,618 at $40.24 | filing |
| 11 May 2026filed 13 May 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $5.4M133,618 at $40.24 | filing |
| 8 May 2026filed 11 May 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $202K5,018 at $40.31 | filing |
| 7 May 2026filed 11 May 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $10.9M271,495 at $40.12 | filing |
| 17 Apr 2026filed 21 Apr 2026 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Sold | $17.2M426,005 at $40.32 | filing |
| 10 Jun 2024filed 10 Jun 2024 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —56,091,177 at $0.00 | filing |
| 10 Jun 2024filed 10 Jun 2024 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —8,000,000 at $0.00 | filing |
| 10 Jun 2024filed 10 Jun 2024 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —298,103 at $0.00 | filing |
| 10 Jun 2024filed 10 Jun 2024 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Code C | —6,551,449 at $0.00 | filing |
| 10 Jun 2024filed 10 Jun 2024 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Code C | —969,218 at $0.00 | filing |
News
Comparing Septerna (NASDAQ:SEPN) and INmune Bio (NASDAQ:INMB)SEPN · themarketsdaily.com · 24 Oct 2026Rapport Therapeutics (NASDAQ:RAPP) Stock: Insider Troy Ignelzi Acquires 5,500 SharesRAPP · dailypolitical.com · 21 Oct 2026Why Is Rapport Therapeutics Stock Trading Higher Today?RAPP · aol.com · 20 Oct 2026Rapport Therapeutics Rockets On Positive, But Mixed, Bipolar DataRAPP · investors.com · 20 Oct 2026Septerna (NASDAQ:SEPN) COO Sells $149,640.00 in StockSEPN · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Third Rock Ventures V, L.P.; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.